Adams R, Finn P, Moes E, Flannery K, Rizzo AS Distractibility in Attention/Deficit/ Hyperactivity Disorder (ADHD): the virtual reality classroom. Child Neuropsychol. 2009 Mar;15(2):120-35. doi: 10.1080/09297040802169077. Epub 2008 Jun 26.
Adams ZW, Roberts WM, Milich R, Fillmore MT Does response variability predict distractibility among adults with attention-deficit/hyperactivity disorder? Psychol Assess. 2011 Jun;23(2):427-36. doi: 10.1037/a0022112.
Adler LD, Nierenberg AA Review of medication adherence in children and adults with ADHD. Postgrad Med. 2010 Jan;122(1):184-91. doi: 10.3810/pgm.2010.01.2112.
Barkley RA Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment. 3rd ed. New York: Guilford Press; 2006.
Berger I, Cassuto H The effect of environmental distractors incorporation into a CPT on sustained attention and ADHD diagnosis among adolescents. J Neurosci Methods. 2014 Jan 30;222:62-8. doi: 10.1016/j.jneumeth.2013.10.012. Epub 2013 Nov 8.
Chang Z, Lichtenstein P, D'Onofrio BM, Sjolander A, Larsson H Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. JAMA Psychiatry. 2014 Mar;71(3):319-25. doi: 10.1001/jamapsychiatry.2013.4174.
Geng JJ Attentional Mechanisms of Distractor Suppression. Current direction in psychological science. 2014;23(2):147-153.
Gerardi M, Cukor J, Difede J, Rizzo A, Rothbaum BO Virtual reality exposure therapy for post-traumatic stress disorder and other anxiety disorders. Curr Psychiatry Rep. 2010 Aug;12(4):298-305. doi: 10.1007/s11920-010-0128-4.
Gershon J, Zimand E, Pickering M, Rothbaum BO, Hodges L A pilot and feasibility study of virtual reality as a distraction for children with cancer. J Am Acad Child Adolesc Psychiatry. 2004 Oct;43(10):1243-9. doi: 10.1097/01.chi.0000135621.23145.05.
Groves PM, Thompson RF Habituation: a dual-process theory. Psychol Rev. 1970 Sep;77(5):419-50. doi: 10.1037/h0029810. No abstract available.
Healey AN, Primus CP, Koutantji M Quantifying distraction and interruption in urological surgery. Qual Saf Health Care. 2007 Apr;16(2):135-9. doi: 10.1136/qshc.2006.019711.
Hoffman HG, Patterson DR, Carrougher GJ, Sharar SR Effectiveness of virtual reality-based pain control with multiple treatments. Clin J Pain. 2001 Sep;17(3):229-35. doi: 10.1097/00002508-200109000-00007.
Hoza B Johnston C, Pillow DR, Ascough JC. Predicting treatment response for childhood attention-deficit/hyperactivity : Introduction of a heuristic model to guide research. Appl Prev Psychol. 12// 2006; 11(4):215-229
Johnston C, Hommersen P, Seipp C Acceptability of behavioral and pharmacological treatments for attention-deficit/hyperactivity disorder: relations to child and parent characteristics. Behav Ther. 2008 Mar;39(1):22-32. doi: 10.1016/j.beth.2007.04.002. Epub 2007 Oct 18.
Kim K, Mundy P Joint attention, social-cognition, and recognition memory in adults. Front Hum Neurosci. 2012 Jun 14;6:172. doi: 10.3389/fnhum.2012.00172. eCollection 2012.
Krueger MW, Gilden D "KnowWare: virtual reality maps for blind people". Stud Health Technol Inform. 1999;62:191-7.
Laird NM, Ware JH Random-effects models for longitudinal data. Biometrics. 1982 Dec;38(4):963-74.
Lalonde G, Henry M, Drouin-Germain A, Nolin P, Beauchamp MH Assessment of executive function in adolescence: a comparison of traditional and virtual reality tools. J Neurosci Methods. 2013 Sep 30;219(1):76-82. doi: 10.1016/j.jneumeth.2013.07.005. Epub 2013 Jul 15.
Maskey M, Lowry J, Rodgers J, McConachie H, Parr JR Reducing specific phobia/fear in young people with autism spectrum disorders (ASDs) through a virtual reality environment intervention. PLoS One. 2014 Jul 2;9(7):e100374. doi: 10.1371/journal.pone.0100374. eCollection 2014.
Melara RD, Tong Y, Rao A Control of working memory: effects of attention training on target recognition and distractor salience in an auditory selection task. Brain Res. 2012 Jan 9;1430:68-77. doi: 10.1016/j.brainres.2011.10.036. Epub 2011 Oct 26.
Milich R, Loney J, Landau S Independent dimensions of hyperactivity and aggression: a validation with playroom observation data. J Abnorm Psychol. 1982 Jun;91(3):183-98. doi: 10.1037//0021-843x.91.3.183. No abstract available.
Milich R, Loney J, Roberts MA Playroom observations of activity level and sustained attention: two-year stability. J Consult Clin Psychol. 1986 Apr;54(2):272-4. doi: 10.1037//0022-006x.54.2.272. No abstract available.
Park J, Waqar S, Kersey T, Modi N, Ong C, Sleep T Effect of distraction on simulated anterior segment surgical performance. J Cataract Refract Surg. 2011 Aug;37(8):1517-22. doi: 10.1016/j.jcrs.2011.01.031.
Parsons TD, Bowerly T, Buckwalter JG, Rizzo AA A controlled clinical comparison of attention performance in children with ADHD in a virtual reality classroom compared to standard neuropsychological methods. Child Neuropsychol. 2007 Jul;13(4):363-81. doi: 10.1080/13825580600943473.
Parsons TD, Rizzo AA Affective outcomes of virtual reality exposure therapy for anxiety and specific phobias: a meta-analysis. J Behav Ther Exp Psychiatry. 2008 Sep;39(3):250-61. doi: 10.1016/j.jbtep.2007.07.007. Epub 2007 Jul 25.
Pluyter JR, Buzink SN, Rutkowski AF, Jakimowicz JJ Do absorption and realistic distraction influence performance of component task surgical procedure? Surg Endosc. 2010 Apr;24(4):902-7. doi: 10.1007/s00464-009-0689-7. Epub 2009 Sep 30.
Roberts MA A behavioral observation method for differentiating hyperactive and aggressive boys. J Abnorm Child Psychol. 1990 Apr;18(2):131-42. doi: 10.1007/BF00910726.
Rothbaum BO, Anderson P, Zimand E, Hodges L, Lang D, Wilson J Virtual reality exposure therapy and standard (in vivo) exposure therapy in the treatment of fear of flying. Behav Ther. 2006 Mar;37(1):80-90. doi: 10.1016/j.beth.2005.04.004. Epub 2006 Feb 24.
Salem Y, Elokda A Use of virtual reality gaming systems for children who are critically ill. J Pediatr Rehabil Med. 2014;7(3):273-6. doi: 10.3233/PRM-140296.
Schweitzer JB, Sulzer-Azaroff B Self-control in boys with attention deficit hyperactivity disorder: effects of added stimulation and time. J Child Psychol Psychiatry. 1995 May;36(4):671-86. doi: 10.1111/j.1469-7610.1995.tb02321.x.
Swanson J Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement. CNS Drugs. 2003;17(2):117-31. doi: 10.2165/00023210-200317020-00004.
Thompson RF, Spencer WA Habituation: a model phenomenon for the study of neuronal substrates of behavior. Psychol Rev. 1966 Jan;73(1):16-43. doi: 10.1037/h0022681. No abstract available.
Thompson RF Habituation: a history. Neurobiol Learn Mem. 2009 Sep;92(2):127-34. doi: 10.1016/j.nlm.2008.07.011. Epub 2008 Sep 10. No abstract available.
Tsujimoto S, Yasumura A, Yamashita Y, Torii M, Kaga M, Inagaki M Increased prefrontal oxygenation related to distractor-resistant working memory in children with attention-deficit/hyperactivity disorder (ADHD). Child Psychiatry Hum Dev. 2013 Oct;44(5):678-88. doi: 10.1007/s10578-013-0361-2.
Wang M, Reid D Virtual reality in pediatric neurorehabilitation: attention deficit hyperactivity disorder, autism and cerebral palsy. Neuroepidemiology. 2011;36(1):2-18. doi: 10.1159/000320847. Epub 2010 Nov 17.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.